<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18031" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Autonomic Dysreflexia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Allen</surname>
            <given-names>Kathrin J.</given-names>
          </name>
          <aff>West Virginia University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Leslie</surname>
            <given-names>Stephen W.</given-names>
          </name>
          <aff>Creighton University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kathrin Allen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Stephen Leslie declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>30</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18031.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Autonomic dysreflexia is a condition that emerges after a spinal cord injury, usually when the damage has occurred above the T6 level. The higher the level of the spinal cord injury, the greater the risk, with up to 90% of patients with cervical spinal or high-thoracic spinal cord injury being susceptible. Dysregulation of the autonomic nervous system leads to an uncoordinated sympathetic response that may result in a potentially life-threatening hypertensive episode when there is a noxious stimulus below the level of the spinal cord injury. In about 85% of cases, this stimulus is from a urological source such as a UTI, a distended bladder, or a clogged Foley catheter. There is a significantly increased risk of stroke by 300% to 400%. Autonomic dysreflexia can occur in susceptible individuals up to 40 times per day. This activity reviews the causes, pathophysiology, presentation, and treatment of autonomic dysreflexia and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of autonomic dysreflexia.</p></list-item><list-item><p>Review the manifestations of autonomic dysreflexia.</p></list-item><list-item><p>Summarize the management options for autonomic dysreflexia.</p></list-item><list-item><p>Outline the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by autonomic dysreflexia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18031&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18031">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-18031.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Autonomic dysreflexia is a condition that emerges soon after a spinal cord injury, usually when the damage has occurred at or above the T6 level. It is generally defined as a syndrome in susceptible spinal cord injured patients that incorporates a sudden, exaggerated reflexive increase in blood pressure in response to a stimulus, usually bladder or bowel distension, originating below the level of the neurological injury. It is usually accompanied by a severe headache, bradycardia, and facial flushing, along with pallor, cold skin, and sweating in the lower part of the body. It is significant because it is a potentially lethal disorder that occurs in about half or more of the potentially susceptible individuals but can usually be easily alleviated by prompt recognition and relatively simple corrective procedures by caregivers.<xref ref-type="bibr" rid="article-18031.r1">[1]</xref>&#x000a0;It is also sometimes known as&#x000a0;autonomic hyperreflexia, hypertensive autonomic crisis, sympathetic hyperreflexia, autonomic spasticity, paroxysmal hypertension, mass reflex, and viscero-autonomic stress syndrome. (Autonomic dysfunction, autonomic neuropathy, and dysautonomia refer to general dysfunction of the autonomic nervous system, which is a distinctly different entity.)</p>
        <p>The higher the level of the spinal cord injury and the more complete, the greater the risk of developing autonomic dysreflexia. Up to 90% of patients with cervical spinal or high-thoracic spinal cord injury are susceptible to the disorder. Dysregulation of the autonomic nervous system leads to an uncoordinated autonomic response that may result in a potentially life-threatening hypertensive episode when there is a noxious stimulus below the level of the spinal cord injury. In about 85% of cases, this stimulus is from a urological source such as a urinary tract infection (UTI), a distended bladder, or a clogged Foley catheter. There is a significantly increased risk of stroke by 300% to 400%. Autonomic dysreflexia can occur in susceptible individuals up to 40 times per day. Patients with traumatic spinal injuries with autonomic dysreflexia have a significantly higher death rate than similarly injured individuals without the disorder.<xref ref-type="bibr" rid="article-18031.r2">[2]</xref><xref ref-type="bibr" rid="article-18031.r3">[3]</xref>&#x000a0;</p>
        <p>The initial presenting complaint is usually a severe headache, typically described as throbbing. Susceptible individuals, usually with spinal cord lesions at or above T6, who complain of a severe headache should immediately have their blood pressure checked. If elevated, a presumptive diagnosis of autonomic dysreflexia can be made.<xref ref-type="bibr" rid="article-18031.r4">[4]</xref><xref ref-type="bibr" rid="article-18031.r5">[5]</xref> Prompt recognition and correction of the disorder, usually just by irrigating or changing their urinary Foley catheter, can be immediately life-saving. Unfortunately, the vast majority of nurses, emergency room staff, and physiotherapists are unfamiliar with&#x000a0;autonomic dysreflexia and are unable to identify or treat it quickly.<xref ref-type="bibr" rid="article-18031.r6">[6]</xref><xref ref-type="bibr" rid="article-18031.r7">[7]</xref>&#x000a0;This is quite problematic as they are often the first healthcare professionals to witness such an event where early recognition and immediate, proper treatment can literally be the difference between life and death.<xref ref-type="bibr" rid="article-18031.r8">[8]</xref></p>
        <p>Fortunately, most episodes are relatively mild and can be managed at home by the patient and their usual caregivers without acute medical intervention. Severe, life-threatening episodes are rarely encountered by most medical personnel except those who work in specialized tertiary care centers. This means that many medical professionals, even emergency personnel, may rarely see this condition acutely in its most severe form and may therefore not be familiar with its early recognition or immediate treatment protocol.<xref ref-type="bibr" rid="article-18031.r9">[9]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-18031.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology is a spinal cord injury, almost always at or above the T6 level. Objectively, an episode is defined as an increase in systolic blood pressure of at least 25 mm Hg or more above baseline.<xref ref-type="bibr" rid="article-18031.r8">[8]</xref>&#x000a0;A significant episode would usually have a systolic blood pressure of at least 150 mmHg or more than 40mmHg above the patient's baseline. The higher the injury level, the greater the severity of the cardiovascular dysfunction. The severity and frequency of autonomic dysreflexia episodes are also associated with the completeness of the spinal cord injury as well as the level. Patients with a complete spinal cord injury are more than three times more likely to develop autonomic dysreflexia than those with incomplete injuries (91% to 27%).<xref ref-type="bibr" rid="article-18031.r10">[10]</xref>&#x000a0;</p>
        <p>Although autonomic dysreflexia has been described in the first days or weeks after the original trauma, it generally does not develop until after the period of spinal shock when reflexes have recovered.<xref ref-type="bibr" rid="article-18031.r8">[8]</xref>&#x000a0;The earliest reported case appeared on the fourth-day post-injury. Most of the patients (92%) who will ultimately develop autonomic dysreflexia will do so within the first year after their injury.<xref ref-type="bibr" rid="article-18031.r11">[11]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-18031.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Autonomic dysreflexia develops in 48% to 70% of patients with a spinal cord injury above the T6 level and is quite unlikely to develop if the injury is below T10.<xref ref-type="bibr" rid="article-18031.r12">[12]</xref>&#x000a0;It has also been infrequently reported in non-traumatic spinal cord injury cases, such as radiation myelopathy and cisplatin-induced polyneuropathy.<xref ref-type="bibr" rid="article-18031.r13">[13]</xref>&#x000a0;</p>
        <p>Patients&#x000a0;prone to this disorder will usually have a documented or personal history of prior episodes, but health professionals need to be alert to an initial presentation without any known prior history of autonomic dysreflexia.<xref ref-type="bibr" rid="article-18031.r8">[8]</xref></p>
      </sec>
      <sec id="article-18031.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Cutaneous or visceral stimulation below the level of the injury initiates afferent impulses to the intermediolateral grey columns of the spinal cord that elicit abnormal reflex sympathetic nervous system activity from T6 to L2. The sympathetic response is exaggerated due to a lack of compensatory descending parasympathetic stimulation and intrinsic post-traumatic hypersensitivity. This leads to diffuse vasoconstriction, typically to the lower two-thirds of the body, and a significant rise in blood pressure despite maximum parasympathetic vasodilatory efforts above the level of injury. In an intact autonomic system, this increased blood pressure activates the carotid sinus and aortic arch baroreceptors leading to a parasympathetic response slowing the heart rate via vagal nerve activity and causing diffuse vasodilation to correct the original increased sympathetic tone.<xref ref-type="bibr" rid="article-18031.r12">[12]</xref></p>
        <p>However, in the setting of a spinal cord injury, the normal corrective parasympathetic response from the medullary vasomotor center cannot travel below the level of the spinal injury, and generalized vasoconstriction affecting the splanchnic, muscular, vascular, and cutaneous arterial circulatory networks continues, ultimately leading to systemic hypertension which is often severe and potentially dangerous. The compensatory vagal and parasympathetic stimulation leads to bradycardia and vasodilation, but only above the level of the spinal cord injury.<xref ref-type="bibr" rid="article-18031.r8">[8]</xref></p>
        <p>The most common stimuli are distention of a hollow viscus, usually the bladder but could also be the rectum. Bladder distention is responsible for about 85% of all cases and is by far the most common trigger followed by fecal impaction.<xref ref-type="bibr" rid="article-18031.r14">[14]</xref> Pressure ulcers or other injuries such as fractures and urinary tract infections are other common causes. Sexual intercourse can also be a stimulus for autonomic dysreflexia. Medical procedures, surgeries, constipation, gastric ulcers, fecal impaction, boils, fractures, dislocations, infections such as epididymitis, pancreatitis, cholecystitis, and labor &#x00026; delivery are all potential triggering causes of autonomic dysreflexia.<xref ref-type="bibr" rid="article-18031.r8">[8]</xref> Pregnancy, in particular, becomes very complicated in patients with a history of autonomic dysreflexia. Such patients should optimally be under the care of an obstetrician with experience in these difficult and complicated cases.</p>
        <p>Pharmacological causes of autonomic dysreflexia are rare, but recently a case was reported in a patient receiving combination therapy with duloxetine and amitriptyline.<xref ref-type="bibr" rid="article-18031.r15">[15]</xref></p>
        <p>Spinal cord injuries below T10 rarely result in autonomic dysreflexia because the splanchnic innervation remains intact and allows for compensatory parasympathetic dilation of the splanchnic vascular network.<xref ref-type="bibr" rid="article-18031.r16">[16]</xref>&#x000a0;Detrusor sphincter dyssynergia is common in patients with spinal cord injuries at risk for autonomic dysreflexia. Such patients would have lesions at or above T6 and void only in small amounts.&#x000a0;</p>
      </sec>
      <sec id="article-18031.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The manifestations are variable and include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Severe headache</p>
          </list-item>
          <list-item>
            <p>Hypertension</p>
          </list-item>
          <list-item>
            <p>Profuse diaphoresis and flushing above the level of injury</p>
          </list-item>
          <list-item>
            <p>Piloerection above the level of injury</p>
          </list-item>
          <list-item>
            <p>Cool, pale skin below the level of injury because of severe vasoconstriction</p>
          </list-item>
          <list-item>
            <p>Visual disturbances</p>
          </list-item>
          <list-item>
            <p>Constricted pupils</p>
          </list-item>
          <list-item>
            <p>Nasal stuffiness</p>
          </list-item>
          <list-item>
            <p>Anxiety or feelings of doom</p>
          </list-item>
          <list-item>
            <p>Nausea&#x000a0;and vomiting</p>
          </list-item>
          <list-item>
            <p>Dizziness</p>
          </list-item>
        </list>
        <p>The initial presenting symptom is typically a severe headache. The headache is usually sudden, severe, throbbing, and bilateral. It may be frontal, temporal, or occipital. This is caused by significant vasodilation superior to the level of injury. When this cerebral vasodilation is combined with dangerously high blood pressure, a potentially lethal stroke may occur. Symptoms may not necessarily correlate with the severity of the blood pressure elevation.&#x000a0;</p>
        <p>Hypertension may be asymptomatic or severe enough to cause a hypertensive crisis complicated by pulmonary edema, left ventricular dysfunction, retinal detachment, intracranial hemorrhage, seizures, or death. Patients with T6 level injuries tend to have systolic blood pressures between 90 and 110 mmHg, but readings should be compared with the patient's usual baseline levels.<xref ref-type="bibr" rid="article-18031.r8">[8]</xref> Bradycardia may also range from minor to resulting in cardiac arrest. Tachycardia is less common than bradycardia but may also occur along with cardiac arrhythmias and atrial fibrillation or flutter.&#x000a0;If the patient has coronary artery disease, an episode of autonomic dysreflexia may cause a&#x000a0;myocardial infarction.</p>
        <p>The combination of dangerously high blood pressure and cerebral vasodilation puts the patient at high risk for a hemorrhagic stroke that can be life-threatening.<xref ref-type="bibr" rid="article-18031.r17">[17]</xref><xref ref-type="bibr" rid="article-18031.r18">[18]</xref></p>
        <p>
<bold>Any patient with paraplegia or quadriplegia&#x000a0;who complains of a severe headache or is found unconscious should immediately&#x000a0;undergo screening for possible autonomic dysreflexia by checking their blood pressure and comparing it to their baseline level. Systolic blood pressure &#x0003e;150 mmHg or &#x0003e;40 mmHg above baseline should be considered highly suggestive of autonomic dysreflexia and appropriate measures should be taken.</bold>
</p>
      </sec>
      <sec id="article-18031.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The evaluation includes obtaining a history of previous autonomic dysreflexia episodes with the triggering event if known, monitoring vital signs, and watching for any developing signs and symptoms. The baseline blood pressure should be known and documented for future reference. Many patients with spinal cord injuries will have hypotension. Orthostatic hypotension is found in over 50% of patients with autonomic dysreflexia.<xref ref-type="bibr" rid="article-18031.r19">[19]</xref></p>
        <p>Start by identifying patients at risk (spinal cord injury at or above the T6 level) and recognize the key initial symptom, which is usually a severe headache from cerebral vasodilation. Should this be encountered,&#x000a0;the next step would be to check the blood pressure. If elevated above the patient's usual baseline, then the patient is at high risk for an episode of autonomic dysreflexia. A systolic blood pressure &#x0003e;150 mmHg or &#x0003e;40 mmHg above baseline levels should be considered indicative of autonomic dysreflexia.</p>
        <p>The likelihood of autonomic dysreflexia is independently predicted by the level of the spinal cord lesion, whether it is complete or incomplete, and the presence of&#x000a0;neurogenic detrusor overactivity.</p>
      </sec>
      <sec id="article-18031.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p><bold>Ask the Patient and Caregiver:</bold>&#x000a0;Since most patients will have endured previous episodes, it is reasonable to ask them what their most common precipitating event is and the usual remedy. Most patients with a history of autonomic dysreflexia will be quite knowledgeable about the condition and are prepared to implement a treatment plan. It is strongly recommended that patients prone to this condition carry an emergency treatment pack or kit with appropriate pharmacological therapies and a card or summary of autonomic dysreflexia to explain the condition and its acute treatment to those unfamiliar with it in emergency situations.<xref ref-type="bibr" rid="article-18031.r8">[8]</xref>&#x000a0;</p>
        <p><bold>Immediate First Steps:</bold> In the event of an episode, the immediate first step is to sit&#x000a0;the patient upright with their legs dangling and remove any tight clothing or constrictive devices, which will help lower their blood pressure orthostatically by inducing the pooling of blood in the abdominal and lower extremity vessels as well as eliminating possible triggering stimuli.<xref ref-type="bibr" rid="article-18031.r20">[20]</xref> Vital signs should be closely monitored, and identification of the triggering stimulus should be immediately attempted. Blood pressure should be checked at least every 5 minutes, and an arterial line should be considered. The noxious stimuli should be corrected as soon as possible.</p>
        <p>Bladder and/or bowel distension are the most common triggering causes, with bladder over-distension being the most likely. Therefore, checking and restoring bladder drainage is immediately recommended as the first source to be investigated.&#x000a0;If the patient has an indwelling catheter, it should be evaluated for obstruction, malfunction, or malpositioning, and a workup for a urinary tract infection should be performed. Irrigation of the catheter with normal saline, warmed if possible, can be performed to determine patency. Minimal volumes of irrigation should be used. If there is any question about the functionality of the Foley catheter, it should be changed immediately. Avoid undue suprapubic pressing, tapping, or palpating the bladder as this may exacerbate the dysreflexia. If the patient does not have a Foley catheter, one should be placed immediately. Prior to placement, anesthetic gel should be administered directly into the urethra and left for a minimum of two minutes if possible. Placement of a Foley catheter in a patient suffering from autonomic dysreflexia may be challenging as the increased sympathetic tone can tighten the urethral sphincter. Use of a coude catheter or a guidewire is recommended if difficulty is encountered in the initial placement of the Foley.<xref ref-type="bibr" rid="article-18031.r21">[21]</xref></p>
        <p>Patients with significantly overdistended bladders are at a markedly increased risk of rebound hypotension, especially if they have already received antihypertensive medication. In such cases, a bladder scan can be used to identify patients at risk with significantly elevated bladder volumes. Blood pressure should be monitored carefully during bladder drainage in patients with known bladder overdistension.&#x000a0;Warmed normal saline should be used for catheter irrigation as cold fluids could trigger further dysreflexic reactions.<xref ref-type="bibr" rid="article-18031.r20">[20]</xref>&#x000a0;</p>
        <p>Urine leakage around unobstructed catheters is often due to bladder spasms that may be associated with dysreflexia episodes. Acutely, a belladonna and opium (B &#x00026; O) suppository is often the most effective, immediate treatment for bladder spasms. Overactive bladder medications such as oxybutynin, trospium, vibegron, and mirabegron can be used both therapeutically and prophylactically. In severe cases, bladder wall injections of botulinum toxin (botox) can be helpful.<xref ref-type="bibr" rid="article-18031.r22">[22]</xref>&#x000a0;A urinary tract infection may also cause bladder spasms without catheter blockage, but such spasms are usually transient and disappear when the UTI is successfully treated.&#x000a0;</p>
        <p>If the blood pressure remains elevated despite optimal bladder management, consideration should be given to a potential bowel problem as the triggering etiology, especially if the blood pressure is &#x0003c;150 mmHg.&#x000a0;A rectal exam should be considered to evaluate for impaction; however, this should be done with care as it can precipitate a worsening dysreflexic crisis due to the rectal stimulation. A topical anesthetic gel applied directly into the rectum has long been recommended to minimize unnecessary stimulation, but recently this has been called into question by a randomized clinical trial that suggested this prolongs care routines and may actually worsen autonomic dysreflexia.<xref ref-type="bibr" rid="article-18031.r8">[8]</xref><xref ref-type="bibr" rid="article-18031.r23">[23]</xref><xref ref-type="bibr" rid="article-18031.r24">[24]</xref>&#x000a0;A suppository can be used, but large volume enemas and vigorous manual or digital rectal stimulation should be avoided. If the systolic blood pressure is &#x0003e;150 mmHg or more than 40 mmHg above the patient's baseline, pharmacological therapy should be utilized to reduce the systolic pressure prior to the rectal examination.</p>
        <p>If neither bladder nor bowel problems appear to be the triggering stimulus, a systematic search for other causes should be undertaken. Relatively frequent triggers include skin lesions, infected or ingrown toenails, infected decubitus ulcers, hip dislocations, fractures, venous thromboses, rectal fissures or abscesses, medication effects (nasal decongestants, sympathomimetic drugs, misoprostol, etc.), gastric or bowel disorders, cholelithiasis, testicular problems such as epididymitis or torsions, sunburn or insect bites, and recent traumas which may be previously unrecognized, among others.<xref ref-type="bibr" rid="article-18031.r8">[8]</xref></p>
        <p>Rarely, pyocystis can cause autonomic dysreflexia in susceptible spinal cord injured patients. (Pyocystis is a lower urinary tract infection in anuric patients where the bladder interior contains purulent material.)&#x000a0; In pyocystis, oral and intravenous antibiotics do not adequately reach the bladder interior. In such situations, an aminoglycoside instillation into the bladder of amikacin (25 mg/100 ml) or gentamicin (80 mg/50-60 ml) has been used successfully to treat the pyocystis, based on culture and sensitivity testing, after initial bladder drainage and irrigation of infected debris and mucus.<xref ref-type="bibr" rid="article-18031.r25">[25]</xref><xref ref-type="bibr" rid="article-18031.r26">[26]</xref>&#x000a0;Another rare cause of autonomic dysreflexia would be a "silent" myocardial infarct, particularly in quadriplegic patients.</p>
        <p>It is important to document the underlying triggering event for the autonomic dysreflexia if possible, especially if it is something uncommon or unusual.</p>
        <p>"Boosting" refers to the deliberate triggering of an episode of autonomic dysreflexia to enhance athletic performance for a sporting event such as the Paralympics. Such activities are strongly discouraged due to the extremely high-risk dangers and hazards it presents to the athletes. While athletic performance can be improved, possibly by up to 10%, boosting is very dangerous, and most sporting events for the disabled, including the Paralympics and the International Paralympic Committee, ban such intentional acts.<xref ref-type="bibr" rid="article-18031.r27">[27]</xref><xref ref-type="bibr" rid="article-18031.r28">[28]</xref><xref ref-type="bibr" rid="article-18031.r29">[29]</xref></p>
        <p><bold>Emergency Antihypertensive Pharmacological Treatment:</bold> If the triggering event cannot be identified and initial maneuvers do not improve the systolic blood pressure below 150 mmHg or less than 40 mmHg above the patient's usual baseline, emergency antihypertensive pharmacologic management should be initiated. Hypertension should be promptly corrected with agents that optimally have a rapid onset but short duration of action.</p>
        <p>Nitroglycerine 2% paste is the recommended initial emergency treatment of severe hypertension in patients with autonomic dysreflexia.<xref ref-type="bibr" rid="article-18031.r30">[30]</xref> One to two inches of nitroglycerine 2% paste should be placed on the skin above the level of the spinal cord injury.<xref ref-type="bibr" rid="article-18031.r30">[30]</xref>&#x000a0;It can easily be removed when the hypertensive crisis is over.<xref ref-type="bibr" rid="article-18031.r30">[30]</xref>&#x000a0;When applying the nitroglycerine paste, spread the gel lightly on the skin and avoid rubbing it in. The application area should be covered with plastic wrapping or waterproof tape to protect it and hold it in place.&#x000a0;Nitrates should not be administered to patients who&#x000a0;may have taken&#x000a0;sildenafil or similar medications within 24 hours (or within 48 hours of taking tadalafil) due to the potential for severe hypotension as they act synergistically. Nitrate therapy has a relatively high risk of rebound hypotension.</p>
        <p>Immediate-release nifedipine 10 mg has also been recommended as the initial medical pharmacotherapy when required. This should be reduced to 5 mg in the elderly and those already taking other antihypertensive medications.<xref ref-type="bibr" rid="article-18031.r31">[31]</xref>&#x000a0;The capsule should be administered with a "bite and swallow" technique. The treatment should be repeated every 20 to 30 minutes as needed up to a maximum of 40 mg/24 hours. Nifedipine is not recommended in patients with coronary artery disease. Sublingual nifedipine is not recommended due to its unpredictable absorption.<xref ref-type="bibr" rid="article-18031.r8">[8]</xref>&#x000a0;&#x000a0;</p>
        <p>Other examples of acceptable antihypertensive treatment would include sublingual and chewable nitrates, sublingual captopril 25 mg., sublingual clonidine (0.2 mg initially followed by 0.1 mg. hourly as needed), intravenous hydralazine (10&#x000a0;to 20 mg slow IV PRN), intravenous labetalol (if the heart rate is not too slow), phentolamine 5 mg IV PRN, sodium nitroprusside (0.5&#x000a0;to 3 mcg/kg/min PRN), diazoxide (20 mg IV bolus), prazosin, and terazosin, among others.<xref ref-type="bibr" rid="article-18031.r23">[23]</xref> Intravenous infusions such as nitroglycerine or clevidipine are also options; however, placement of an arterial line is recommended for close monitoring and optimal titration of the infusion.<xref ref-type="bibr" rid="article-18031.r8">[8]</xref>&#x000a0;Rebound hypotension can occur for five hours after administration of antihypertensive medications, particularly nitrates, so these drugs should be used with caution in this population with frequent monitoring.<xref ref-type="bibr" rid="article-18031.r8">[8]</xref></p>
        <p>
<bold>Summary of Preferred Initial Pharmacological Antihypertensive Therapies for Emergency Use in Autonomic Dysreflexia:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Nitroglycerine 2% Paste: Dosage 1&#x000a0;to 2 inches (placed on the non-hairy chest or elsewhere above the level of spinal injury) - Onset of activity: 3&#x000a0;to 5 minutes. The duration of action is 8 hours. The maximum dose is 5 inches.</p>
          </list-item>
          <list-item>
            <p>Nifedipine "Bite and Swallow": Dosage 10 mg. - Onset of activity: 10&#x000a0;to 20 minutes - Peak activity in 1 hour - May repeat every 20 to 30 minutes. The duration of action is 4 hours. The maximum dose is 40 mg./24 hours.</p>
          </list-item>
          <list-item>
            <p>Sublingual Captopril: Dosage 25 mg. -&#x000a0;Onset of activity: 20&#x000a0;to 30 minutes - May repeat in 1 hour as needed. Peak activity in 1 hour. The duration of action is 4 hours. The maximum dose is 50 mg.</p>
          </list-item>
          <list-item>
            <p>Sublingual Clonidine: Dosage 0.2 mg. initially followed by 0.1 mg. hourly as needed. - Onset of activity: 10&#x000a0;to 20 minutes. Peak activity in 1 hour. The duration of action is 12 hours. The maximum dose is 0.8 mg.</p>
          </list-item>
        </list>
        <p>After emergency hypertensive treatment, the patient's blood pressure should be monitored for at least an additional two hours. The need for ongoing blood pressure monitoring should not deter clinicians from using pharmacological agents when necessary as uncontrolled high blood pressure combined with cerebral vasodilation is particularly dangerous and potentially lethal. Patients should be warned about potential side effects of medical therapy, including tachycardia, rebound hypotension, nausea, vomiting, drowsiness, flushing, and cardiac arrhythmias.</p>
        <p><bold>Hospital Admission:</bold> Hospital admission is recommended if the patient is responding poorly to treatment, the underlying etiology of the episode remains unknown or in pregnancy. Transfer to an intensive care unit should be considered if control of the autonomic dysreflexia and its associated hypertensive crisis has not been achieved within 30 minutes. Discharge is dependent on identifying the underlying cause and/or the episodes cease. Those with continuing or frequent episodes of autonomic dysreflexia should be well prepared with an emergency treatment kit, including necessary supplies and instructions, and only when their caregivers are able to comfortably treat the condition outside the hospital.<xref ref-type="bibr" rid="article-18031.r31">[31]</xref>&#x000a0;</p>
        <p><bold>Pregnancy:</bold> Women with a T6 or higher spinal cord injury who become pregnant are at risk for developing a dysreflexia episode during labor and delivery. In women with spinal cord injuries, the symptoms of labor may only be some&#x000a0;abdominal discomfort, increased spasticity, and autonomic dysreflexia. Epidural anesthesia has been reportedly the best choice for controlling autonomic dysreflexia during labor. For cesarean sections or instrumentally assisted deliveries, a spinal or epidural anesthetic may be used. The anesthetic level should be extended to T10 to minimize the risk for autonomic dysreflexia. The American College of Obstetrics and Gynecology states that&#x000a0;it is vital that any obstetrician caring for a pregnant patient with a spinal cord injury be familiar with the complications related to such injuries.</p>
        <p><bold>Procedures:</bold> Patients with spinal cord injuries and autonomic dysreflexia often undergo medical procedures and surgeries, such as urologic instrumentation, that can trigger dysreflexic episodes. General or regional anesthesia may be used for these procedures when feasible.&#x000a0;Regional anesthesia in the form of a spinal anesthetic has the advantage of blocking both limbs of the reflex arc and thereby&#x000a0;avoids autonomic dysreflexia. However, determining the level of anesthesia can be difficult, and administration/placement of the regional anesthetic may be challenging in patients with spinal cord injuries. An epidural catheter may also be considered for longer cases as it has the advantage of being able to be "topped off." Epidurals are subject to incomplete blocks and might be even more difficult to place. If general anesthesia is used and hypertension or other evidence of a dysreflexic episode develops, deepening the level of anesthesia by increasing the anesthetic agent often alleviates the episode. If hypertension remains unresolved by deepening the anesthetic, antihypertensive medications should be used until the stimulus is withdrawn.</p>
        <p>Patients susceptible to autonomic dysreflexia undergoing routine urological diagnostic procedures, such as cystoscopy and urodynamics, should be continuously monitored.<xref ref-type="bibr" rid="article-18031.r14">[14]</xref><xref ref-type="bibr" rid="article-18031.r30">[30]</xref>&#x000a0;Emergency pharmacotherapy for autonomic dysreflexia should be immediately available.<xref ref-type="bibr" rid="article-18031.r17">[17]</xref><xref ref-type="bibr" rid="article-18031.r30">[30]</xref><xref ref-type="bibr" rid="article-18031.r32">[32]</xref>&#x000a0;If a patient develops autonomic dysreflexia during a urologic study or examination, the activity should be immediately terminated and the bladder promptly drained.<xref ref-type="bibr" rid="article-18031.r30">[30]</xref> Hemodynamic monitoring should be maintained with appropriate pharmacotherapy if the condition continues despite these measures.<xref ref-type="bibr" rid="article-18031.r30">[30]</xref></p>
        <p><bold>Prophylaxis: </bold>Optimal management of patients with spinal cord injuries who are prone to autonomic dysreflexia is usually achieved by a multidisciplinary team which may include a spinal rehabilitation specialist, urologist, gastroenterologist, and other specialists who are experienced in these cases. For example, patients may be asked to perform intermittent self-catheterization more often (5-6 times a day) than similar patients with neurogenic bladders who are not as susceptible to autonomic dysreflexia. Bowel management may include abdominal massage, periodic careful digital rectal stimulation, regular suppositories, and routine laxatives. Additional prophylactic measures include careful positioning, seating guidelines, use of appropriate pads along with pressure-relieving cushions and mattresses, as well as periodic inspections for skin lesions to minimize ulcers and breakdowns.<xref ref-type="bibr" rid="article-18031.r8">[8]</xref>&#x000a0;Daily antihypertensive medication solely for autonomic dysreflexia prophylaxis is generally not recommended.<xref ref-type="bibr" rid="article-18031.r30">[30]</xref></p>
        <p>The use of&#x000a0;10 ml of 2% lidocaine administered intravesically&#x000a0;4-6 minutes prior to&#x000a0;routine Foley catheter changes has been shown to significantly reduce episodes of autonomic dysreflexia in patients at high risk.<xref ref-type="bibr" rid="article-18031.r33">[33]</xref>&#x000a0;Botulinum toxin injections for chemical denervation of the bladder muscle have also been shown to reduce the incidence of autonomic dysreflexia in susceptible individuals.<xref ref-type="bibr" rid="article-18031.r22">[22]</xref><xref ref-type="bibr" rid="article-18031.r34">[34]</xref><xref ref-type="bibr" rid="article-18031.r35">[35]</xref>&#x000a0;</p>
        <p>Minocycline has been shown to have a neuroprotective effect in animal testing models but has not yet been shown to have a similar clinical benefit in humans.<xref ref-type="bibr" rid="article-18031.r31">[31]</xref><xref ref-type="bibr" rid="article-18031.r36">[36]</xref><xref ref-type="bibr" rid="article-18031.r37">[37]</xref><xref ref-type="bibr" rid="article-18031.r38">[38]</xref></p>
        <p>While not the current standard of care, there is some evidence that gabapentin might be somewhat beneficial as a prophylactic agent in some spinal cord injured patients, particularly when a low dose is used before scheduled procedures to help mitigate the expected autonomic dysreflexic response.<xref ref-type="bibr" rid="article-18031.r39">[39]</xref><xref ref-type="bibr" rid="article-18031.r40">[40]</xref><xref ref-type="bibr" rid="article-18031.r41">[41]</xref>&#x000a0;</p>
        <p>Noninvasive transcutaneous spinal cord stimulation has been shown in a limited study to significantly mitigate the degree of hypertension during a period of autonomic dysreflexia and even prevent it altogether.<xref ref-type="bibr" rid="article-18031.r42">[42]</xref>&#x000a0;Although this was an early, preliminary study, this Canadian report describes a promising new tool to help minimize or even prevent dangerous hypertensive episodes of autonomic dysreflexia in susceptible individuals.</p>
      </sec>
      <sec id="article-18031.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Acute glomerulonephritis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Anxiety</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Cushing's syndrome</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Drug use or overdose (e.g., stimulants, especially alcohol, cocaine, or levothyroxine)</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hyperaldosteronism</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hyperthyroidism</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Intracranial hemorrhage</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Ischemic stroke</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Nephritic and nephrotic syndrome</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Polycystic kidney disease</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18031.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of autonomic dysreflexia is usually good as long as the condition is recognized, patients and caregivers are adequately educated, proper precautions are taken, and emergency corrective treatment is initiated promptly. However, unrecognized or untreated autonomic dysreflexia can result in potentially catastrophic consequences. Fortunately, mortality is relatively rare.&#x000a0;</p>
      </sec>
      <sec id="article-18031.s11" sec-type="Complications">
        <title>Complications</title>
        <p>The most serious complication of autonomic dysreflexia is a hemorrhagic stroke which can be serious and even deadly. If not adequately treated, autonomic dysreflexia causes a sustained, severe hypertension which can result in a variety of problems such as a myocardial ischemia or infarction, renal failure, pulmonary edema, retinal hemorrhage or a cerebral bleed resulting in a potentially disabling or lethal stroke.&#x000a0;A literature review of patients with autonomic dysreflexia who developed serious complications from the disorder found 32 reported cases. Of these, 22% died as an immediate result of problems directly related to an episode of autonomic dysreflexia. Most (72%) of the serious complications involved the central nervous system, 22% were cardiovascular and 6% were pulmonary.<xref ref-type="bibr" rid="article-18031.r17">[17]</xref></p>
        <p>Other potential complications are related to their underlying spinal injury such as pressure sores, decubiti, constipation, and urinary tract infections. But in patients prone to significant autonomic dysreflexia episodes, such problems can potentially lead to a dysreflexic episode.</p>
      </sec>
      <sec id="article-18031.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients prone to autonomic dysreflexia and their caregivers should be well informed and fully educated about the disorder, its recognition, severity, and immediate treatment. Such patients should consider traveling with an emergency treatment bag with information on autonomic dysreflexia, treatment instructions, and basic supplies to implement corrective therapy.</p>
      </sec>
      <sec id="article-18031.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>The six "B"s that are the common causes of autonomic dysreflexia:</p>
        <list list-type="order">
          <list-item>
            <p>Bladder (catheter blockage, distension, stones, infection, spasms)</p>
          </list-item>
          <list-item>
            <p>Bowel (constipation, impaction)</p>
          </list-item>
          <list-item>
            <p>Back passage (hemorrhoids, rectal issues, anal abscess, fissure)</p>
          </list-item>
          <list-item>
            <p>Boils (skin lesions, infected ulcers, decubiti)</p>
          </list-item>
          <list-item>
            <p>Bones (fractures, dislocations)</p>
          </list-item>
          <list-item>
            <p>Babies (pregnancy)</p>
          </list-item>
        </list>
        <p>Autonomic dysreflexia should be strongly suspected in any spinal cord injured patient with a lesion at or above T6 who complains of a headache. A blood pressure reading should be taken immediately, and corrective treatment should start if the patient's blood pressure is significantly elevated above baseline as most spinal cord injured patients have low blood pressure. A systolic blood pressure &#x0003e;150 mmHg or &#x0003e;40 mmHg above baseline is highly suggestive of autonomic dysreflexia. Bladder distension from urinary retention or a blocked Foley is the single most common cause of this disorder, and irrigating or changing the catheter is often immediately curative. Quick recognition and rapid alleviation of the underlying stimulus may be life-saving.</p>
        <p>Any paraplegic or quadriplegic who complains of a severe headache should immediately be checked for possible autonomic dysreflexia by checking their blood pressure. If elevated, the patient should be moved to a sitting position with their legs dangling, and any constricting clothing or binders should be loosened. A careful check should be made for the initiating stimulus, which most often is a distended bladder. The majority of these patients will have Foley catheters which can easily become kinked or obstructed, so this should be checked first by either irrigation or by changing the catheter. Patients without urinary catheters should immediately have a Foley placed. If no treatable initiating cause is discovered, it should be treated as a hypertensive emergency as the patient is at high risk for a potentially life-threatening stroke if the blood pressure remains uncontrolled. In such situations, immediate, emergency treatment of the hypertensive crisis is most easily accomplished by applying 1 to 2 inches of 2% nitroglycerine paste directly to the skin above the level of the spinal injury or nifedipine 10 mg. using a "bite and swallow" technique.&#x000a0;</p>
        <p>Susceptible patients (any spinal cord injury patient who has had at least one significant episode of autonomic dysreflexia) should always carry an emergency treatment kit or bag with necessary supplies (such as Foley catheters (council catheters and coude tipped are preferred), guidewires, sterile lubricant, a tube of 2% lidocaine anesthetic gel, normal saline irrigation fluid, catheter tip syringe for irrigation, 10 cc syringes to empty and sterile water to fill the catheter balloons, emergency antihypertensive medications (such as nitroglycerine paste and nifedipine), instructions/information on autonomic dysreflexia such as a copy of this review, blood pressure cuff, etc.). A medical information card should be included containing the patient's identification information, address, emergency contacts, list of medical problems, allergies, usual medications, causes of prior episodes of autonomic dysreflexia, and baseline blood pressure. A simplified summary of the management of autonomic dysreflexia should also be in the emergency kit to assist healthcare personnel unfamiliar with the problem in the event of an emergency.</p>
        <p>Having such an emergency kit immediately available could be life-saving!</p>
      </sec>
      <sec id="article-18031.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Patients with spinal cord injury are usually managed by an interprofessional team that includes the trauma surgeon, internist, neurologist, urologist, and emergency department physician. Autonomic&#x000a0;dysreflexia&#x000a0;should be strongly suspected in any spinal cord injured patient with a lesion above T6 who complains of a headache. A blood pressure reading should be taken immediately, and corrective treatment started if the patient's blood pressure is significantly elevated as most spinal cord injured patients have low blood pressure. Bladder distension from urinary retention or a blocked Foley is the single most common cause of this disorder, and irrigating or changing the catheter is often immediately curative. Quick recognition and rapid alleviation of the underlying stimulus may be life-saving.</p>
        <p>Nurses play a key role in the monitoring of patients with autonomic dysreflexia, and they are often the first healthcare personnel to identify the problem. These patients are best managed in the ICU with 24/7 monitoring.</p>
        <p>Autonomic dysreflexia patients are also prone to deep vein thrombosis and pressure sores; hence appropriate prophylactic measures should be undertaken.<xref ref-type="bibr" rid="article-18031.r38">[38]</xref><xref ref-type="bibr" rid="article-18031.r43">[43]</xref></p>
        <p>
<bold>Additional Resources</bold>
</p>
        <p>An excellent free informational website devoted to patient and professional education about spinal cord injuries can be found at the International Spinal Cord Society (ISCoS) website. It provides educational modules designed for all stages and levels of spinal cord injury for both laypersons and healthcare personnel.<xref ref-type="bibr" rid="article-18031.r8">[8]</xref></p>
        <p>Other recommended resources are&#x000a0;the recent Guidelines on Adult Neurogenic Lower Urinary Tract Dysfunction: Diagnosis and Evaluation (Part 1)&#x000a0;and Treatment and Follow-up (Part 2)&#x000a0;published in November 2021 jointly by the American Urological Association (AUA) and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU).<xref ref-type="bibr" rid="article-18031.r30">[30]</xref><xref ref-type="bibr" rid="article-18031.r44">[44]</xref></p>
      </sec>
      <sec id="article-18031.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18031&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18031">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/neurology/autonomic-dysreflexia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=18031">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18031/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18031">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-18031.s16">
        <title>References</title>
        <ref id="article-18031.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cowan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lakra</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Autonomic dysreflexia in spinal cord injury.</article-title>
            <source>BMJ</source>
            <year>2020</year>
            <month>Oct</month>
            <day>02</day>
            <volume>371</volume>
            <fpage>m3596</fpage>
            <pub-id pub-id-type="pmid">33008797</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghajarzadeh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rahimi Foroushani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nedjat</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sheikhrezaei</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saberi</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Survival Analysis in Patients with Chronic Traumatic Spinal Cord Injury.</article-title>
            <source>Iran J Public Health</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>48</volume>
            <issue>12</issue>
            <fpage>2260</fpage>
            <page-range>2260-2269</page-range>
            <pub-id pub-id-type="pmid">31993395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morgan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Recognition and management of autonomic dysreflexia in patients with a spinal cord injury.</article-title>
            <source>Emerg Nurse</source>
            <year>2020</year>
            <month>Jan</month>
            <day>03</day>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>22</fpage>
            <page-range>22-27</page-range>
            <pub-id pub-id-type="pmid">31820597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaydok</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Nurses and physiotherapists' knowledge levels on autonomic dysreflexia in a rehabilitation hospital.</article-title>
            <source>J Spinal Cord Med</source>
            <year>2023</year>
            <month>Jul</month>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>569</fpage>
            <page-range>569-573</page-range>
            <pub-id pub-id-type="pmid">34855570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tederko</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ugniewski</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bobecka-Weso&#x00142;owska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tarnacka</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>What do physiotherapists and physiotherapy students know about autonomic dysreflexia?</article-title>
            <source>J Spinal Cord Med</source>
            <year>2021</year>
            <month>May</month>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>418</fpage>
            <page-range>418-424</page-range>
            <pub-id pub-id-type="pmid">31403393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Str&#x0010d;i&#x00107;</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Marki&#x00107;</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The knowledge about autonomic dysreflexia among nursing and physiotherapy students.</article-title>
            <source>J Spinal Cord Med</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>42</volume>
            <issue>6</issue>
            <fpage>791</fpage>
            <page-range>791-796</page-range>
            <pub-id pub-id-type="pmid">29485358</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jackson</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Acland</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Knowledge of autonomic dysreflexia in the emergency department.</article-title>
            <source>Emerg Med J</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>28</volume>
            <issue>10</issue>
            <fpage>866</fpage>
            <page-range>866-9</page-range>
            <pub-id pub-id-type="pmid">20947918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lakra</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Swayne</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Christofi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Autonomic dysreflexia in spinal cord injury.</article-title>
            <source>Pract Neurol</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>532</fpage>
            <page-range>532-538</page-range>
            <pub-id pub-id-type="pmid">34353860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khastgir</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Drake</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Abrams</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Recognition and effective management of autonomic dysreflexia in spinal cord injuries.</article-title>
            <source>Expert Opin Pharmacother</source>
            <year>2007</year>
            <month>May</month>
            <volume>8</volume>
            <issue>7</issue>
            <fpage>945</fpage>
            <page-range>945-56</page-range>
            <pub-id pub-id-type="pmid">17472540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Del Fabro</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Mejia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nemunaitis</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>An investigation of the relationship between autonomic dysreflexia and intrathecal baclofen in patients with spinal cord injury.</article-title>
            <source>J Spinal Cord Med</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>102</fpage>
            <page-range>102-105</page-range>
            <pub-id pub-id-type="pmid">28406070</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Andrade</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>de Ara&#x000fa;jo</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Andrade</surname>
                <given-names>Kda R</given-names>
              </name>
              <name>
                <surname>de Souza</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Chianca</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>[Autonomic dysreflexia and nursing interventions for patients with spinal cord injury].</article-title>
            <source>Rev Esc Enferm USP</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>47</volume>
            <issue>1</issue>
            <fpage>93</fpage>
            <page-range>93-100</page-range>
            <pub-id pub-id-type="pmid">23515808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karlsson</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Autonomic dysreflexia.</article-title>
            <source>Spinal Cord</source>
            <year>1999</year>
            <month>Jun</month>
            <volume>37</volume>
            <issue>6</issue>
            <fpage>383</fpage>
            <page-range>383-91</page-range>
            <pub-id pub-id-type="pmid">10432257</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saito</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Autonomic dysreflexia in a case of radiation myelopathy and cisplatin-induced polyneuropathy.</article-title>
            <source>Spinal Cord Ser Cases</source>
            <year>2020</year>
            <month>Aug</month>
            <day>13</day>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <pub-id pub-id-type="pmid">32792478</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shergill</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Arya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hamid</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Khastgir</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>The importance of autonomic dysreflexia to the urologist.</article-title>
            <source>BJU Int</source>
            <year>2004</year>
            <month>May</month>
            <volume>93</volume>
            <issue>7</issue>
            <fpage>923</fpage>
            <page-range>923-6</page-range>
            <pub-id pub-id-type="pmid">15142138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parke</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Reyes</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Autonomic Dysreflexia as a Potential Adverse Effect of Duloxetine and Amitriptyline Combination Therapy: A Case Report.</article-title>
            <source>PM R</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>214</fpage>
            <page-range>214-218</page-range>
            <pub-id pub-id-type="pmid">30036681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eldahan</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Rabchevsky</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Autonomic dysreflexia after spinal cord injury: Systemic pathophysiology and methods of management.</article-title>
            <source>Auton Neurosci</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>209</volume>
            <fpage>59</fpage>
            <page-range>59-70</page-range>
            <pub-id pub-id-type="pmid">28506502</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Krassioukov</surname>
                <given-names>AV</given-names>
              </name>
            </person-group>
            <article-title>Life-threatening outcomes associated with autonomic dysreflexia: a clinical review.</article-title>
            <source>J Spinal Cord Med</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>2</fpage>
            <page-range>2-10</page-range>
            <pub-id pub-id-type="pmid">24090418</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dolinak</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Balraj</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Autonomic dysreflexia and sudden death in people with traumatic spinal cord injury.</article-title>
            <source>Am J Forensic Med Pathol</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>95</fpage>
            <page-range>95-8</page-range>
            <pub-id pub-id-type="pmid">17525555</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gibbons</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Freeman</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance.</article-title>
            <source>Neurology</source>
            <year>2006</year>
            <month>Jul</month>
            <day>11</day>
            <volume>67</volume>
            <issue>1</issue>
            <fpage>28</fpage>
            <page-range>28-32</page-range>
            <pub-id pub-id-type="pmid">16832073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trop</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Autonomic dysreflexia and its urological implications: a review.</article-title>
            <source>J Urol</source>
            <year>1991</year>
            <month>Dec</month>
            <volume>146</volume>
            <issue>6</issue>
            <fpage>1461</fpage>
            <page-range>1461-9</page-range>
            <pub-id pub-id-type="pmid">1942319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghaffary</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yohannes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Villanueva</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>A practical approach to difficult urinary catheterizations.</article-title>
            <source>Curr Urol Rep</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>565</fpage>
            <page-range>565-79</page-range>
            <pub-id pub-id-type="pmid">23959835</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haynes</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Osbun</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Ancillary benefits of bladder chemodenervation for SCI neurogenic bladder.</article-title>
            <source>Spinal Cord Ser Cases</source>
            <year>2018</year>
            <volume>4</volume>
            <fpage>83</fpage>
            <pub-id pub-id-type="pmid">30245851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wecht</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Management of blood pressure disorders in individuals with spinal cord injury.</article-title>
            <source>Curr Opin Pharmacol</source>
            <year>2022</year>
            <month>Feb</month>
            <volume>62</volume>
            <fpage>60</fpage>
            <page-range>60-63</page-range>
            <pub-id pub-id-type="pmid">34915401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lucci</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>McGrath</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Inskip</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Sarveswaran</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Willms</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Claydon</surname>
                <given-names>VE</given-names>
              </name>
            </person-group>
            <article-title>Clinical recommendations for use of lidocaine lubricant during bowel care after spinal cord injury prolong care routines and worsen autonomic dysreflexia: results from a randomised clinical trial.</article-title>
            <source>Spinal Cord</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>58</volume>
            <issue>4</issue>
            <fpage>430</fpage>
            <page-range>430-440</page-range>
            <pub-id pub-id-type="pmid">31767947</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sherwin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hasen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>May</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Single-dose intravesical amikacin instillation for pyocystis in a patient with autonomic dysreflexia: A case report.</article-title>
            <source>J Spinal Cord Med</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>45</volume>
            <issue>6</issue>
            <fpage>965</fpage>
            <page-range>965-968</page-range>
            <pub-id pub-id-type="pmid">33983103</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamel</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Gardner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tourchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tart</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Raheem</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Houston</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bissada</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Pyocystis: a systematic review.</article-title>
            <source>Int Urol Nephrol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>49</volume>
            <issue>6</issue>
            <fpage>917</fpage>
            <page-range>917-926</page-range>
            <pub-id pub-id-type="pmid">28265966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gee</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Krassioukov</surname>
                <given-names>AV</given-names>
              </name>
            </person-group>
            <article-title>Boosting in Elite Athletes with Spinal Cord Injury: A Critical Review of Physiology and Testing Procedures.</article-title>
            <source>Sports Med</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>45</volume>
            <issue>8</issue>
            <fpage>1133</fpage>
            <page-range>1133-42</page-range>
            <pub-id pub-id-type="pmid">26009300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mazzeo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Santamaria</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Iavarone</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>"Boosting" in Paralympic athletes with spinal cord injury: doping without drugs.</article-title>
            <source>Funct Neurol</source>
            <year>2015</year>
            <season>Apr-Jun</season>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>91</fpage>
            <page-range>91-8</page-range>
            <pub-id pub-id-type="pmid">26415788</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blauwet</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Benjamin-Laing</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Stomphorst</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Van de Vliet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pit-Grosheide</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Willick</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Testing for boosting at the Paralympic games: policies, results and future directions.</article-title>
            <source>Br J Sports Med</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>47</volume>
            <issue>13</issue>
            <fpage>832</fpage>
            <page-range>832-7</page-range>
            <pub-id pub-id-type="pmid">23681503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ginsberg</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Boone</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Cameron</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Gousse</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kaufman</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Keays</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kennelly</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Lemack</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Rovner</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Souter</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Kraus</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Diagnosis and Evaluation.</article-title>
            <source>J Urol</source>
            <year>2021</year>
            <month>Nov</month>
            <volume>206</volume>
            <issue>5</issue>
            <fpage>1097</fpage>
            <page-range>1097-1105</page-range>
            <pub-id pub-id-type="pmid">34495687</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Novak</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Autonomic Disorders.</article-title>
            <source>Am J Med</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>132</volume>
            <issue>4</issue>
            <fpage>420</fpage>
            <page-range>420-436</page-range>
            <pub-id pub-id-type="pmid">30308186</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walter</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kn&#x000fc;pfer</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Cragg</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Leitner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Mehnert</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Krassioukov</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Schubert</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Curt</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kessler</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Prediction of autonomic dysreflexia during urodynamics: a prospective cohort study.</article-title>
            <source>BMC Med</source>
            <year>2018</year>
            <month>Apr</month>
            <day>13</day>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <pub-id pub-id-type="pmid">29650001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Solinsky</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Linsenmeyer</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Intravesical lidocaine decreases autonomic dysreflexia when administered prior to catheter change.</article-title>
            <source>J Spinal Cord Med</source>
            <year>2018</year>
            <month>Sep</month>
            <day>10</day>
            <volume>42</volume>
            <issue>5</issue>
            <fpage>1</fpage>
            <page-range>1-5</page-range>
            <pub-id pub-id-type="pmid">30199342</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fougere</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Currie</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Nigro</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Stothers</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rapoport</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Krassioukov</surname>
                <given-names>AV</given-names>
              </name>
            </person-group>
            <article-title>Reduction in Bladder-Related Autonomic Dysreflexia after OnabotulinumtoxinA Treatment in Spinal Cord Injury.</article-title>
            <source>J Neurotrauma</source>
            <year>2016</year>
            <month>Sep</month>
            <day>15</day>
            <volume>33</volume>
            <issue>18</issue>
            <fpage>1651</fpage>
            <page-range>1651-7</page-range>
            <pub-id pub-id-type="pmid">26980078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jung</surname>
                <given-names>IY</given-names>
              </name>
              <name>
                <surname>Mo</surname>
                <given-names>KI</given-names>
              </name>
              <name>
                <surname>Leigh</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Effect of intravesical botulinum toxin injection on symptoms of autonomic dysreflexia in a patient with chronic spinal cord injury: a case report.</article-title>
            <source>J Spinal Cord Med</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>42</volume>
            <issue>6</issue>
            <fpage>806</fpage>
            <page-range>806-809</page-range>
            <pub-id pub-id-type="pmid">28486884</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Squair</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Ruiz</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>MMZ</given-names>
              </name>
              <name>
                <surname>Sarafis</surname>
                <given-names>ZK</given-names>
              </name>
              <name>
                <surname>Sachdeva</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gopaul</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tetzlaff</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Krassioukov</surname>
                <given-names>AV</given-names>
              </name>
            </person-group>
            <article-title>Minocycline Reduces the Severity of Autonomic Dysreflexia after Experimental Spinal Cord Injury.</article-title>
            <source>J Neurotrauma</source>
            <year>2018</year>
            <month>Dec</month>
            <day>15</day>
            <volume>35</volume>
            <issue>24</issue>
            <fpage>2861</fpage>
            <page-range>2861-2871</page-range>
            <pub-id pub-id-type="pmid">30113266</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kupfer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kucer</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Kupfer</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Formal</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Persons With Chronic Spinal Cord Injuries in the Emergency Department: a Review of a Unique Population.</article-title>
            <source>J Emerg Med</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>55</volume>
            <issue>2</issue>
            <fpage>206</fpage>
            <page-range>206-212</page-range>
            <pub-id pub-id-type="pmid">29807681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lofters</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chaudhry</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Slater</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schuler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Milligan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Guilcher</surname>
                <given-names>SJT</given-names>
              </name>
            </person-group>
            <article-title>Preventive care among primary care patients living with spinal cord injury.</article-title>
            <source>J Spinal Cord Med</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>42</volume>
            <issue>6</issue>
            <fpage>702</fpage>
            <page-range>702-708</page-range>
            <pub-id pub-id-type="pmid">29424661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rabchevsky</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Duale</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lyttle</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>O'Dell</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Kitzman</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Gabapentin for spasticity and autonomic dysreflexia after severe spinal cord injury.</article-title>
            <source>Spinal Cord</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>49</volume>
            <issue>1</issue>
            <fpage>99</fpage>
            <page-range>99-105</page-range>
            <pub-id pub-id-type="pmid">20514053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eldahan</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Gollihue</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Rabchevsky</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Paradoxical effects of continuous high dose gabapentin treatment on autonomic dysreflexia after complete spinal cord injury.</article-title>
            <source>Exp Neurol</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>323</volume>
            <fpage>113083</fpage>
            <pub-id pub-id-type="pmid">31678138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rabchevsky</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Lyttle</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Eldahan</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>O'Dell</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Popovich</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Kitzman</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Donohue</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Effects of gabapentin on muscle spasticity and both induced as well as spontaneous autonomic dysreflexia after complete spinal cord injury.</article-title>
            <source>Front Physiol</source>
            <year>2012</year>
            <volume>3</volume>
            <fpage>329</fpage>
            <pub-id pub-id-type="pmid">22934077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sachdeva</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nightingale</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Pawar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kalimullina</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mesa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marwaha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>AMM</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Krassioukov</surname>
                <given-names>AV</given-names>
              </name>
            </person-group>
            <article-title>Noninvasive Neuroprosthesis Promotes Cardiovascular Recovery After Spinal Cord Injury.</article-title>
            <source>Neurotherapeutics</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>1244</fpage>
            <page-range>1244-1256</page-range>
            <pub-id pub-id-type="pmid">33791969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davidson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Cardiovascular Physiology and Responses to Sexual Activity in Individuals Living with Spinal Cord Injury.</article-title>
            <source>Top Spinal Cord Inj Rehabil</source>
            <year>2017</year>
            <season>Winter</season>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-19</page-range>
            <pub-id pub-id-type="pmid">29339873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18031.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ginsberg</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Boone</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Cameron</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Gousse</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kaufman</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Keays</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kennelly</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Lemack</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Rovner</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Souter</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Kraus</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up.</article-title>
            <source>J Urol</source>
            <year>2021</year>
            <month>Nov</month>
            <volume>206</volume>
            <issue>5</issue>
            <fpage>1106</fpage>
            <page-range>1106-1113</page-range>
            <pub-id pub-id-type="pmid">34495688</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
